Market News AIOpen the app

LifeMD, Inc. signed a $12.5 million loan deal with rules for repayment and financial operations.

New sharesRead the original at SEC EDGAR
Bad for LFMD

LifeMD’s pharmacy subsidiaries received $12.5 million, but the loan pledges their assets, carries at least 11.50% interest, and limits other borrowing. It also requires at least $150 million in sales over 12 months, so the costs and limits outweigh the added cash.

LFMD · LifeMD, Inc.

AI read · Bad for LFMD

The AI's read

The cash gives LifeMD funds to use. But the interest rate cannot fall below 11.50%, and the loan is backed by borrower assets. LifeMD must also keep sales at $150 million over 12 months and get lender approval for most new borrowing. These costs and limits outweigh the added cash.

Get alerts for LFMD

Follow LifeMD, Inc. (LFMD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LFMD
Free on the App Store and Google Play, or on the web.